(Nasdaq: ALBT) Hits Our Hump Day Radar Early (Low Float With 5 Explosive Potential Catalysts)

Consider keeping an eye on this one — it's not your average story.

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored (Nasdaq: ALBT) Hits Our Hump Day Radar Early (Low Float With 5 Explosive Potential Catalysts) *Get Our Updates Faster—Tap Here To Receive SMS Alerts* February 17th Greetings, Friend! Consider keeping an eye on this one — it’s not your average story. This innovative, commercial-stage company is pushing the boundaries where regenerative medicine, cellular therapy, and diagnostics meet. Through advanced scientific platforms and smart collaborations, the team is driving meaningful progress that could transform the way complex health issues are addressed. And there’s another reason it stands out... This profile’s float is exceptionally tight — under 4Mn shares — which means the potential for daily volatility could pack a punch. After wrapping up a major acquisition at the end of 2025 and kicking off 2026 with headline-making developments, this Nasdaq-listed company is firmly on our radar: *Avalon GloboCare Corp. (Nasdaq: ALBT)* Avalon GloboCare Corp. is a developer of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. Avalon is currently marketing the KetoAir™ breathalyzer device, which is owned and manufactured by Qi Diagnostics Limited, and plans to develop additional diagnostic uses of the breathalyzer technology. Delivering Precision Diagnostics and Laboratory Services Avalon achieves and fosters seamless integration of unique verticals to bridge and accelerate innovative research, bio-process development, clinical programs and product commercialization. Research and Development Avalon is focused on bringing forward intellectual property through joint patent filings with the Massachusetts Institute of Technology (MIT), led by Professor Shuguang Zhang as Principal Investigator.  Using the unique QTY code protein design platform, six water-soluble variant cytokine receptors have been successfully designed and tested to show binding affinity to the respective cytokines. The company is currently focused on bringing forward the intellectual property associated with this program through joint patent submissions. KetoAir™ Breathalyzer Avalon is exploring the commercialization and development of a versatile breathalyzer system. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units (ppm, part-per-million) such that the user will know his/her real-time ketosis status: inadequate ketosis (0-3.99 ppm), mild ketosis (4-9.99 ppm), optimal ketosis (10-40 ppm), or alarming level (> 40 ppm). The breathalyzer is registered with the United States FDA as a Class I medical device (US FDA registration # 3026284320). Check Out Sources Here: ALBT Website. ALBT Website. ----- These 5 Potential Catalysts Could Lend (Nasdaq: ALBT) A Breakout Spark #1. ALBT Has A Very Low Float (Volatility Potential May Be Explosive). Sporting a float of roughly 3.77Mn shares, according to Yahoo Finance, volatility potential could pop up in a flash. #2. Avalon GloboCare Eliminates Majority of Debentures Through $2.6Mn Conversion, Strengthening Balance Sheet, Reduces Overhang. Avalon GloboCare significantly improved its financial standing by converting $2.6Mn of outstanding debentures into common st-ock, eliminating most of its debt from the June 2024 financing round. This move enhances balance sheet health, capital efficiency, and Nasdaq compliance. Avalon’s CEO, Meng Li, emphasized that the conversion not only reduces financial overhang but also increases flexibility to advance its diagnostics, intellectual property, and AI initiatives. With this strategic milestone, Avalon positions itself for sustainable growth and long-term shareholder value creation. #3. Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary. Avalon GloboCare’s subsidiary, Avalon Quantum AI LLC, filed a U.S. provisional patent for a proprietary AI system enabling automated, verifiable video commentary. The evidence-constrained technology addresses transparency and traceability challenges in generative media, supporting compliance in regulated markets like finance and news. By pioneering verifiable AI media infrastructure, Avalon strengthens its position as a leader in trustworthy, enterprise-grade generative technology for high-value communication and publishing sectors. #4. Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform. Avalon GloboCare announced the FDA establishment registration renewal for KetoAir™, its handheld breathalyzer for ketogenic health management. The company aims to launch KetoAir™ in both B2B and B2C channels via Catch-Up™, its AI-powered short-form video SaaS platform operated by Avalon Quantum AI. This initiative aims to expand marketing efficiency, digital engagement, and adoption.  Avalon CEO, Meng Li, emphasized that the dual-market rollout and FDA renewal mark key milestones, positioning Avalon to integrate AI-driven marketing with next-generation wellness technology for stronger consumer and enterprise reach. #5. Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-St-ock Transaction. Avalon GloboCare acquired RPM Interactive, a generative AI software company, in an all-stock transaction that strengthens equity compliance with Nasdaq requirements. RPM’s Catch-Up SaaS platform automatically creates engaging short-form videos using AI commentary and avatars for diverse content markets. The acquisition led to the creation of Avalon Quantum AI LLC, aligning Avalon’s health products with digital publishing innovations. Avalon CEO, Meng Li, stated that integrating RPM’s AI technology enhances Avalon’s marketing power, boosts brand visibility, and supports long-term growth in precision wellness and generative media. ----- We're doing it. Coverage is officially underway on Avalon GloboCare Corp. (Nasdaq: ALBT). Updates will be out soon. Keep your eyes peeled. All the best, Dane James Editor Market Pulse Today (Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.) *MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Avalon GloboCare Corp. (ALBT:US) previously changed their symbol from Avalon GloboCare Corp. (AVCO:US) Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 02/17/2026 and ending on 02/18/2026 to publicly disseminate information about (ALBT:US) via digital communications. Under this agreement, TD Media LLC has paid Thousand Sun Media LLC seven thousand five hundred USD ("Funds"). To date, including under the previously described agreement, Thousand Sun Media LLC has been paid fourteen thousand USD ("Funds"). These Funds were part of the fifty thousand USD funds that TD Media LLC received from a third party named Awareness Consulting Network LLC who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (ALBT:US). Please see important disclosure information here: https://marketpulsetoday.com/disclosure/albt-oojh9/#details

Market Pulse Today | 1314 E LAS OLAS BLVD UNIT #2170 | FORT LAUDERDALE, FL 33301 US Unsubscribe | Update Profile | Our Privacy Policy | Constant Contact Data Notice